PTJ
VECT

Paul Tudor Jones’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Paul Tudor Jones’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-45,184
Closed -$244K – 2830
2022
Q2 		$244K Buy
+45,184
New +$243K 0.01% 1696

Other funds holding VECT

CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Paul Tudor Jones's VECT Position: Q3 2022 in Review

Paul Tudor Jones sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2022, closing a stake of 45,184 shares — an estimated $244K sold.

Paul Tudor Jones first reported a position in VECT in Q2 2022 and held it in 1 quarter. The position peaked at $244K in Q2 2022. 21 funds tracked by Wall St. Rank hold VECT as of Q3 2022.

  • Paul Tudor Jones reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Paul Tudor Jones sold 45,184 VectivBio Holding AG Ordinary Shares shares in Q3 2022, an estimated $244K.
  • Paul Tudor Jones first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2022 and held it in 1 quarter.
  • Paul Tudor Jones's VectivBio Holding AG Ordinary Shares position peaked at $244K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2022.

Based on Tudor Investment Corp's 13F filing for Q3 2022, filed 14 Nov 2022.